Who is sponsoring NCT04455295?

NCT04455295 is sponsored by Arkansas Tech University.

What drugs are being tested in NCT04455295?

Interventions in NCT04455295: Transdermal Vagus Nerve Stimulation (tVNS).

What condition does NCT04455295 study?

NCT04455295 studies no Condition, Electroencephalography, Pupil Diameter.

Is NCT04455295 still recruiting?

NCT04455295 is currently status unknown. Last updated 28 February 2024.

Last reviewed 2024-02-28 · How we verify

NCT04455295

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation

Status unknown NA Last updated 28 February 2024

What this trial tests

NA trial testing Transdermal Vagus Nerve Stimulation (tVNS) in no Condition in 55 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 June 2025

1 June 2025

Quick facts

Lead sponsor	Arkansas Tech University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	55
Start date	1 September 2020
Primary completion	1 June 2025
Estimated completion	1 June 2025
Sites	1 location across United States

Drugs / interventions tested

Transdermal Vagus Nerve Stimulation (tVNS)

Conditions studied

no Condition — all drugs for no Condition →
Electroencephalography — all drugs for Electroencephalography →
Pupil Diameter — all drugs for Pupil Diameter →

Sponsor

Arkansas Tech University

Who can join

18 and older, any sex, with no Condition or Electroencephalography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the capacity of non-invasive vagus nerve stimulation, applied at the ear, to alter to measures of locus coeruleus output pupil diameter and EEG alpha power. Non-invasive alteration in locus coeruleus output is of interest in regard to basic science and has potential clinical implications in a number of conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Arkansas Tech University trials

Trials by the same sponsor.

NCT03854539 — Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04455295 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arkansas Tech University
Last refreshed: 28 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04455295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing